{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:15:04Z","timestamp":1761948904022,"version":"build-2065373602"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"General Projects of Jiangsu Provincial Administration of Traditional Chinese Medicine","award":["MS2021009"],"award-info":[{"award-number":["MS2021009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s13300-025-01802-y","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:53:36Z","timestamp":1759755216000},"page":"2171-2192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Mechanisms of Inflammatory Factors and the Total Load of Cerebral Small Vessel Disease in Diabetic Retinopathy and Cognitive Impairment"],"prefix":"10.1007","volume":"16","author":[{"given":"Junjun","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siman","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenguo","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"8","key":"1802_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3949\/ccjm.91a.24028","volume":"91","author":"DD Chong","year":"2024","unstructured":"Chong DD, Das N, Singh RP. Diabetic retinopathy: screening, prevention, and treatment. Cleve Clin J Med. 2024;91(8):503\u201310.","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"1802_CR2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.08.010803","volume":"8","author":"P Song","year":"2018","unstructured":"Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010803.","journal-title":"J Glob Health"},{"issue":"12","key":"1802_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/bjophthalmol-2017-310316","volume":"101","author":"G Zhang","year":"2017","unstructured":"Zhang G, Chen H, Chen W, Zhang M. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1802_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/dom.16015","volume":"27","author":"J Ma","year":"2025","unstructured":"Ma J, Dong Y, Liu J, Gao S, Quan J. The role of GRB2 in diabetes, diabetes complications and related disorders. Diabetes Obes Metab. 2025;27(1):23\u201324. https:\/\/doi.org\/10.1111\/dom.16015.","journal-title":"Diabetes Obes Metab"},{"key":"1802_CR5","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.2147\/DMSO.S470297","volume":"17","author":"X Zhu","year":"2024","unstructured":"Zhu X, Jiang D, Zhang H, Cai R, Wang Y, Hua F. An investigation of the correlation between retinal nerve fiber layer thickness with blood biochemical indices and cognitive dysfunction in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2024;17:3315\u201323.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1802_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1332237","volume":"15","author":"A Pujol","year":"2024","unstructured":"Pujol A, Sanchis P, Tamayo MI, et al. Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial). Front Endocrinol (Lausanne). 2024;15:1332237.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1802_CR7","doi-asserted-by":"publisher","first-page":"103727","DOI":"10.1016\/j.numecd.2024.08.020","volume":"35","author":"W Zhang","year":"2025","unstructured":"Zhang W, Wang Q, Liu H, et al. Systemic inflammation markers and the prevalence of hypertension in 8- to 17-year-old children and adolescents: a NHANES cross-sectional study. Nutr Metab Cardiovasc Dis. 2025;35(2):103727.","journal-title":"Nutr Metab Cardiovasc Dis."},{"issue":"15","key":"1802_CR8","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/nu16152464","volume":"16","author":"SS Stephenson","year":"2024","unstructured":"Stephenson SS, Kravchenko G, Korycka-Bloch R, Kostka T, Soltysik BK. How immunonutritional markers are associated with age, sex, body mass index and the most common chronic diseases in the hospitalized geriatric population\u2014a cross sectional study. Nutrients. 2024;16(15):2464.","journal-title":"Nutrients."},{"issue":"29","key":"1802_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039041","volume":"103","author":"Y Liu","year":"2024","unstructured":"Liu Y, Qiu T, Fu Z, et al. Systemic immune-inflammation index and serum glucose-potassium ratio predict poor prognosis in patients with spontaneous cerebral hemorrhage: an observational study. Medicine (Baltimore). 2024;103(29):e39041.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1802_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40618-024-02426-y","volume":"48","author":"A Mangone","year":"2025","unstructured":"Mangone A, Favero V, Prete A, et al. Inflammation-based scores in a large cohort of adrenocortical carcinoma and adrenocortical adenoma: role of the hormonal secretion pattern. J Endocrinol Investig. 2025;48(1):81\u201390. https:\/\/doi.org\/10.1007\/s40618-024-02426-y.","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"1802_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/medicina60060855","volume":"60","author":"NT Tabakoglu","year":"2024","unstructured":"Tabakoglu NT, Celik M. Investigation of the systemic immune inflammation (SII) index as an indicator of morbidity and mortality in type 2 diabetic retinopathy patients in a 4-year follow-up period. Medicina (Kaunas). 2024;60(6):855. https:\/\/doi.org\/10.3390\/medicina60060855.","journal-title":"Medicina (Kaunas)"},{"key":"1802_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115569","volume":"212","author":"Y Yang","year":"2023","unstructured":"Yang Y, Jiang G, Huang R, Liu Y, Chang X, Fu S. Targeting the NLRP3 inflammasome in diabetic retinopathy: from pathogenesis to therapeutic strategies. Biochem Pharmacol. 2023;212:115569.","journal-title":"Biochem Pharmacol"},{"key":"1802_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.727998","volume":"15","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang Z, Zhang M, Cao Y, Yun W. Correlation between retinal microvascular abnormalities and total magnetic resonance imaging burden of cerebral small vessel disease in patients with type 2 diabetes. Front Neurosci. 2021;15:727998.","journal-title":"Front Neurosci"},{"issue":"Suppl 1","key":"1802_CR14","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u2013S42.","journal-title":"Diabetes Care"},{"issue":"1","key":"1802_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ophtha.2019.09.025","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy. Ophthalmology. 2020;127(1):66\u2013145.","journal-title":"Ophthalmology"},{"issue":"9","key":"1802_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FR, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677\u201382.","journal-title":"Ophthalmology"},{"issue":"2","key":"1802_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7861\/clinmed.2021-0792","volume":"22","author":"TH Fung","year":"2022","unstructured":"Fung TH, Patel B, Wilmot EG, Amoaku WM. Diabetic retinopathy for the non-ophthalmologist. Clin Med. 2022;22(2):112\u20136.","journal-title":"Clin Med"},{"issue":"3","key":"1802_CR18","first-page":"242","volume":"16","author":"A Ghamdi","year":"2020","unstructured":"Ghamdi A. Clinical predictors of diabetic retinopathy progression; a systematic review. Curr Diabetes Rev. 2020;16(3):242\u20137.","journal-title":"Curr Diabetes Rev"},{"issue":"12","key":"1802_CR19","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41433-019-0494-z","volume":"33","author":"M Saw","year":"2019","unstructured":"Saw M, Wong VW, Ho IV, Liew G. New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy. Eye (London). 2019;33(12):1842\u201351.","journal-title":"Eye (London)"},{"issue":"3","key":"1802_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229665","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu L, Quang ND, Banu R, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS ONE. 2020;15(3):e0229665.","journal-title":"PLoS ONE"},{"issue":"4","key":"1802_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/hr.2010.263","volume":"34","author":"DFJ Lopes","year":"2011","unstructured":"Lopes DFJ, Silva KC, Lopes DFJ. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res. 2011;34(4):413\u201322.","journal-title":"Hypertens Res"},{"key":"1802_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1304512","volume":"15","author":"XF Wang","year":"2024","unstructured":"Wang XF, Zhang XW, Liu YJ, et al. The causal effect of hypertension, intraocular pressure, and diabetic retinopathy: a Mendelian randomization study. Front Endocrinol (Lausanne). 2024;15:1304512.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1802_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1244601","volume":"14","author":"D Gong","year":"2023","unstructured":"Gong D, Fang L, Cai Y, et al. Development and evaluation of a risk prediction model for diabetes mellitus type 2 patients with vision-threatening diabetic retinopathy. Front Endocrinol (Lausanne). 2023;14:1244601.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1802_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01415-3","volume":"19","author":"Y Chou","year":"2020","unstructured":"Chou Y, Ma J, Su X, Zhong Y. Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy. Lipids Health Dis. 2020;19(1):241.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"1802_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.18240\/ijo.2021.09.21","volume":"14","author":"N Yang","year":"2021","unstructured":"Yang N, Lu YF, Yang X, Jiang K, Sang AM, Wu HQ. Association between cystatin C and diabetic retinopathy among type 2 diabetic patients in China: a meta-analysis. Int J Ophthalmol. 2021;14(9):1430\u201340.","journal-title":"Int J Ophthalmol"},{"key":"1802_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1302127","volume":"14","author":"J Zhou","year":"2023","unstructured":"Zhou J, Zhu L, Li Y. Association between the triglyceride glucose index and diabetic retinopathy in type 2 diabetes: a meta-analysis. Front Endocrinol (Lausanne). 2023;14:1302127.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1802_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8757996","volume":"2021","author":"Y Pan","year":"2021","unstructured":"Pan Y, Zhong S, Zhou K, et al. Association between diabetes complications and the triglyceride-glucose index in hospitalized patients with type 2 diabetes. J Diabetes Res. 2021;2021:8757996.","journal-title":"J Diabetes Res"},{"issue":"3","key":"1802_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/jpm13030495","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Lu Q, Zhang M, Yang L, Shen X. The u-shape relationship between triglyceride-glucose index and the risk of diabetic retinopathy among the US population. J Pers Med. 2023;13(3):495. https:\/\/doi.org\/10.3390\/jpm13030495.","journal-title":"J Pers Med"},{"issue":"1","key":"1802_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.151","volume":"4","author":"S Srinivasan","year":"2021","unstructured":"Srinivasan S, Singh P, Kulothungan V, Sharma T, Raman R. Relationship between triglyceride glucose index, retinopathy and nephropathy in type 2 diabetes. Endocrinol Diabetes Metab. 2021;4(1):e00151.","journal-title":"Endocrinol Diabetes Metab"},{"key":"1802_CR30","doi-asserted-by":"publisher","first-page":"1302615","DOI":"10.3389\/fpubh.2023.1302615","volume":"11","author":"YY Zhang","year":"2023","unstructured":"Zhang YY, Chen BX, Chen Z, Wan Q. Correlation study of renal function indices with diabetic peripheral neuropathy and diabetic retinopathy in T2DM patients with normal renal function. Front Public Health. 2023;11:1302615.","journal-title":"Front Public Health"},{"key":"1802_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.906760","volume":"10","author":"Y Guo","year":"2022","unstructured":"Guo Y, Liu S, Xu H. Uric acid and diabetic retinopathy: a systematic review and meta-analysis. Front Public Health. 2022;10:906760.","journal-title":"Front Public Health"},{"issue":"3","key":"1802_CR32","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2020.030502","volume":"30","author":"S Kastelan","year":"2020","unstructured":"Kastelan S, Oreskovic I, Biscan F, Kastelan H, Gverovic AA. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (Zagreb). 2020;30(3):030502.","journal-title":"Biochem Med (Zagreb)"},{"key":"1802_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1115031","volume":"14","author":"RH Wang","year":"2023","unstructured":"Wang RH, Wen WX, Jiang ZP, et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol. 2023;14:1115031.","journal-title":"Front Immunol"},{"key":"1802_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1088778","volume":"14","author":"Q Shi","year":"2023","unstructured":"Shi Q, Wang Q, Wang Z, Lu J, Wang R. Systemic inflammatory regulators and proliferative diabetic retinopathy: a bidirectional Mendelian randomization study. Front Immunol. 2023;14:1088778.","journal-title":"Front Immunol"},{"issue":"8","key":"1802_CR35","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3390\/biomedicines11082106","volume":"11","author":"AM Dascalu","year":"2023","unstructured":"Dascalu AM, Serban D, Tanasescu D, et al. The value of white cell inflammatory biomarkers as potential predictors for diabetic retinopathy in type 2 diabetes mellitus (T2DM). Biomedicines. 2023;11(8):2106. https:\/\/doi.org\/10.3390\/biomedicines11082106.","journal-title":"Biomedicines"},{"key":"1802_CR36","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.2147\/DMSO.S378284","volume":"15","author":"J Zeng","year":"2022","unstructured":"Zeng J, Chen M, Feng Q, et al. The platelet-to-lymphocyte ratio predicts diabetic retinopathy in type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2022;15:3617\u201326.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"1802_CR37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.18240\/ijo.2024.05.12","volume":"17","author":"Y Gao","year":"2024","unstructured":"Gao Y, Lu RX, Tang Y, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in patients with type 2 diabetes at different stages of diabetic retinopathy. Int J Ophthalmol. 2024;17(5):877\u201382.","journal-title":"Int J Ophthalmol"},{"issue":"Suppl 2","key":"1802_CR38","first-page":"53","volume":"28","author":"A Moreno","year":"2013","unstructured":"Moreno A, Lozano M, Salinas P. Diabetic retinopathy. Nutr Hosp. 2013;28(Suppl 2):53\u20136.","journal-title":"Nutr Hosp"},{"issue":"1","key":"1802_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00640-5","volume":"18","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Shue F, Bu G, Kanekiyo T. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease. Mol Neurodegener. 2023;18(1):46.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1802_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266974","volume":"17","author":"E Biffi","year":"2022","unstructured":"Biffi E, Turple Z, Chung J, Biffi A. Retinal biomarkers of cerebral small vessel disease: a systematic review. PLoS ONE. 2022;17(4):e0266974.","journal-title":"PLoS ONE"},{"key":"1802_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103042","volume":"70","author":"V Korann","year":"2022","unstructured":"Korann V, Suhas S, Appaji A, et al. Association between retinal vascular measures and brain white matter lesions in schizophrenia. Asian J Psychiatr. 2022;70:103042.","journal-title":"Asian J Psychiatr"},{"issue":"4","key":"1802_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1177\/0271678X20929430","volume":"41","author":"ES Hoogeveen","year":"2021","unstructured":"Hoogeveen ES, Pelzer N, Ghariq E, et al. Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. J Cereb Blood Flow Metab. 2021;41(4):831\u201340.","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01802-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:10:03Z","timestamp":1761948603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01802-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01802-y","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"type":"print","value":"1869-6953"},{"type":"electronic","value":"1869-6961"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Junjun Miao, Shi Chen, Xinyi Sun, Yun She, Lijuan Wang, Siman Liu, Jiangyi Yu, Jing Ge, and Zhenguo Qiao declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Medical Ethics Committee of Jiangsu Provincial Hospital of Chinese Medicine (ethics approval no.: 2023NL-034-01). All patients provided written informed consent. The study was carried out in accordance with the Declaration of Helsinki. Clinical trial number: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}